1. Home
  2. TVTX vs SEDG Comparison

TVTX vs SEDG Comparison

Compare TVTX & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SEDG
  • Stock Information
  • Founded
  • TVTX 2008
  • SEDG 2006
  • Country
  • TVTX United States
  • SEDG Israel
  • Employees
  • TVTX N/A
  • SEDG N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SEDG Semiconductors
  • Sector
  • TVTX Health Care
  • SEDG Technology
  • Exchange
  • TVTX Nasdaq
  • SEDG Nasdaq
  • Market Cap
  • TVTX 1.4B
  • SEDG 1.1B
  • IPO Year
  • TVTX N/A
  • SEDG 2015
  • Fundamental
  • Price
  • TVTX $14.53
  • SEDG $17.36
  • Analyst Decision
  • TVTX Strong Buy
  • SEDG Hold
  • Analyst Count
  • TVTX 15
  • SEDG 24
  • Target Price
  • TVTX $33.57
  • SEDG $16.63
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • SEDG 6.5M
  • Earning Date
  • TVTX 07-31-2025
  • SEDG 08-06-2025
  • Dividend Yield
  • TVTX N/A
  • SEDG N/A
  • EPS Growth
  • TVTX N/A
  • SEDG N/A
  • EPS
  • TVTX N/A
  • SEDG N/A
  • Revenue
  • TVTX $273,533,000.00
  • SEDG $916,537,000.00
  • Revenue This Year
  • TVTX $73.84
  • SEDG $24.24
  • Revenue Next Year
  • TVTX $46.72
  • SEDG $29.02
  • P/E Ratio
  • TVTX N/A
  • SEDG N/A
  • Revenue Growth
  • TVTX 75.65
  • SEDG N/A
  • 52 Week Low
  • TVTX $6.80
  • SEDG $10.24
  • 52 Week High
  • TVTX $25.29
  • SEDG $38.48
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 40.17
  • SEDG 47.15
  • Support Level
  • TVTX $13.88
  • SEDG $13.73
  • Resistance Level
  • TVTX $15.04
  • SEDG $24.66
  • Average True Range (ATR)
  • TVTX 0.67
  • SEDG 1.56
  • MACD
  • TVTX 0.04
  • SEDG -0.33
  • Stochastic Oscillator
  • TVTX 36.93
  • SEDG 33.21

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

Share on Social Networks: